NCT06595979View on ClinicalTrials.gov

Intraventricular Administration of Intracranial Infections Caused by （Carbapenem-resistant Gram-negative Bacilli）CRGNB

RecruitingOBSERVATIONAL
Enrollment

222

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Intracranial Infections
Interventions
DRUG

Polymyxin B

Participants in this group will receive polymyxin B administered directly into the brain (intracranial administration) without intravenous (IV) infusion.

Trial Locations (3)

310000

RECRUITING

The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

315000

RECRUITING

Ningbo Medical Center Lihuili Hospital, Ningbo

325000

RECRUITING

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

All Listed Sponsors
collaborator

Ningbo Medical Center Lihuili Hospital

OTHER_GOV

collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER